• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[乳腺癌中DNA聚合酶α免疫反应性的增殖活性研究]

[A study of the proliferative activity of DNA polymerase alpha immunoreactivity in breast cancer].

作者信息

Nishimura R, Nagao K, Matsuda M, Baba K, Matsuoka Y, Ueno Y, Morinaga H, Nagase H, Miyayama O, Hamada T

机构信息

Dept. of Surgery, Kumamoto Municipal Hospital.

出版信息

Gan No Rinsho. 1989 Oct;35(12):1417-20.

PMID:2681877
Abstract

DNA polymerase alpha activity is associated with cell proliferation, independently of the cell cycle phase, and a simple and reproducible method for the immunohistochemical demonstration of DNA polymerase alpha has been developed. In an analysis of a total of 76 human breast cancer tissues using this procedure, the clinico-pathological findings revealed that only the estrogen receptor (ER) significantly correlated with the DNA polymerase alpha activity. Therefore, this suggests that ER-negative tumors had a higher proliferative activity.

摘要

DNA聚合酶α活性与细胞增殖相关,与细胞周期阶段无关,并且已经开发出一种简单且可重复的免疫组织化学方法来显示DNA聚合酶α。使用该方法对总共76个人类乳腺癌组织进行分析,临床病理结果显示只有雌激素受体(ER)与DNA聚合酶α活性显著相关。因此,这表明ER阴性肿瘤具有更高的增殖活性。

相似文献

1
[A study of the proliferative activity of DNA polymerase alpha immunoreactivity in breast cancer].[乳腺癌中DNA聚合酶α免疫反应性的增殖活性研究]
Gan No Rinsho. 1989 Oct;35(12):1417-20.
2
[Expression of steroid receptors and DNA synthesis in male breast cancer].[男性乳腺癌中类固醇受体的表达与DNA合成]
Pathologica. 2003 Feb;95(1):31-6.
3
Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors.乳腺癌中雄激素受体的免疫组织化学显示及其与其他预后因素的关系。
J Pathol. 1993 May;170(1):31-5. doi: 10.1002/path.1711700106.
4
17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.人乳腺导管原位癌及导管内增生性病变中的17β-羟基类固醇脱氢酶1型和2型
Anticancer Res. 2000 Mar-Apr;20(2B):1101-8.
5
Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in breast carcinoma by real-time polymerase chain reaction.通过实时聚合酶链反应对乳腺癌中雌激素受体α和β信使核糖核酸表达进行定量分析。
Cancer. 2000 Oct 15;89(8):1732-8. doi: 10.1002/1097-0142(20001015)89:8<1732::AID-CNCR13>3.0.CO;2-2.
6
Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.356例腋窝淋巴结阴性乳腺癌中p53、c-erbB-2、拓扑异构酶IIα表达、DNA倍体、激素受体状态及增殖之间的相关性:预后意义
J Pathol. 1999 Jan;187(2):207-16. doi: 10.1002/(SICI)1096-9896(199901)187:2<207::AID-PATH223>3.0.CO;2-U.
7
Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers.乳腺癌中雌激素受体α和β以及孕激素受体表达的评估及其与临床病理因素和增殖标志物Ki-67的相关性
Hum Pathol. 2008 May;39(5):720-30. doi: 10.1016/j.humpath.2007.09.019. Epub 2008 Jan 30.
8
Immunohistochemical analysis of the functional status of estrogen receptor cascade in breast cancer.
Neoplasma. 1998;45(2):83-7.
9
Presence of erbB2 mRNA in the plasma of breast cancer patients is associated with circulating tumor cells and negative estrogen and progesterone receptor status.乳腺癌患者血浆中erbB2 mRNA的存在与循环肿瘤细胞以及雌激素和孕激素受体阴性状态相关。
Breast Cancer Res Treat. 2006 May;97(1):49-55. doi: 10.1007/s10549-005-9086-7.
10
Ploidy, proliferative activity and estrogen receptor content in human breast cancer.人类乳腺癌中的倍体、增殖活性和雌激素受体含量
Cytometry. 1982 Jul;3(1):36-41. doi: 10.1002/cyto.990030109.